China NMPA Inspection - Zhaoqing Kaijie Technology Co., Ltd. - January 02, 2020

The National Medical Products Administration (NMPA) of China issued a public notification on January 2, 2020, announcing an unannounced inspection of Zhaoqing Kaijie Technology Co., Ltd. Identified with index number JGXX-2020-10001, this document serves as an official record of the NMPA's regulatory oversight activities. The NMPA is the primary regulatory body responsible for the supervision and administration of drugs, medical devices, and cosmetics within China. While the notification confirms that an unannounced inspection of Zhaoqing Kaijie Technology Co., Ltd. was conducted or initiated, the provided public record does not detail the specific dates of the inspection, beyond the publication date of the notification. Furthermore, the notification itself does not contain information regarding any main violations, issues identified during the inspection, or specific findings against the regulatory framework. Consequently, details about any required corrective actions or enforcement measures resulting from this particular inspection are not included within this public announcement. The document primarily functions as a formal announcement of regulatory activity, underscoring the NMPA's commitment to ensuring compliance within its regulated industries, without disclosing the outcomes of the inspection.